[The impact of COVID-19 in a cohort of patients with systemic sclerosis].

María Del Pilar Cruz-Domínguez Susana Isabel Morales-Montalvo Olga Lidia Vera-Lastra Berenice López-Zamora Irvin Ordoñez-González Gabriela Medina Cinthya Paola López-Burgos Daniel Héctor Montes-Cortés Luis Javier Jara-Quezada

Published in: Revista medica del Instituto Mexicano del Seguro Social (2023)

COVID-19 disease in patients with SSc can be overcome in most cases, even when they are ILD and were using immunosuppressants at the time of infection with the SARS-CoV-2 virus.

Keyphrases

sars cov
systemic sclerosis
interstitial lung disease
coronavirus disease
respiratory syndrome coronavirus
rheumatoid arthritis
idiopathic pulmonary fibrosis